Skip to main content
. 2018 Sep 20;7(1):161–184. doi: 10.1016/j.jcmgh.2018.09.008

Figure 8.

Figure 8

IC50 values for huTGO2 dose-response curves. IC50 values for tumor-derived gastric organoids (huTGO) treated with (A) epirubicin with or without HER2I, (B) oxaliplatin with or without HER2I, or (C) 5-FU with or without HER2I. CI, confidence interval.